Federico Vozzi

Federico Vozzi is a Senior Scientist at the Istituto di Fisiologia Clinica del CNR in Pisa, where he is the Principal Investigator of the Biomimetic Materials and Biological Tissue Engineering Laboratory. In 2007, he received a Ph.D. in Drug Science from the University of Pisa. His research focuses on tissue engineering for cardiovascular applications, 3D printing, development and testing of bioreactors, and New Approach Methodologies (NAMs) for chemical risk assessment. He has strong experience in studies mainly focused on cardiovascular systems, where cardiomyocytes/endothelial and smooth muscle cells were studied in their modulation of phenotypic characteristics through the support of tissue engineering systems (scaffolds, bioreactors): a type of approach useful to recreate and mimic the physiological environment. Thanks to the help of advanced molecular biology techniques, a wide spectrum of analytical assays is routinely performed to support the comprehension of pathophysiological mechanisms of cardiac and metabolic diseases. He was the coordinator or unit leader of several projects and is the Technical Manager of the Horizon Europe REGENT-HEART project. Dr. Federico Vozzi is the author and co-author of > 100 scientific papers in international journals with peer review, presentations to national and international conferences, and the author of 3 patents. He is co-founder of “Kirkstall Ltd”, a UK biotechnology company operating within the global organ-on-a-chip market.